Synthesis of peptidomimics through sugar-based scaffolds.

Methods Mol Med

Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Universite Rene Descartes, Paris, France.

Published: October 2012

Poor oral bioavailability, low metabolic stability towards proteolysis and rapid excretion via both liver and kidneys displayed by innumerable peptides of potential therapeutic value has generated an intensive search for peptidomimics (1-2). A possible approach of such nonpeptidal peptidomimics is to replace the peptide by a scaffold that distributes in the space the peptidal side chains of amino acids essential for biological activity and mimics the bioactive conformation of the peptide.

Download full-text PDF

Source
http://dx.doi.org/10.1385/0-89603-517-4:227DOI Listing

Publication Analysis

Top Keywords

synthesis peptidomimics
4
peptidomimics sugar-based
4
sugar-based scaffolds
4
scaffolds poor
4
poor oral
4
oral bioavailability
4
bioavailability low
4
low metabolic
4
metabolic stability
4
stability proteolysis
4

Similar Publications

There is much demand for crystalline covalent helical polymers. Inspired by the helical structure of collagen, we synthesized a covalent helical polymer wherein the repeating dipeptide Gly-Pro units are connected by triazole linkages. We synthesized an azide and alkyne-modified dipeptide monomer made up of the repeating amino acid sequence of collagen.

View Article and Find Full Text PDF

Self-Assembly of Minimal Peptoid Sequences.

ACS Macro Lett

April 2020

Department of Pure & Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, U.K.

Peptoids are biofunctional -substituted glycine peptidomimics. Their self-assembly is of fundamental interest because they demonstrate alternatives to conventional peptide structures based on backbone chirality and beta-sheet hydrogen bonding. The search for self-assembling, water-soluble "minimal" sequences, be they peptide or peptidomimic, is a further challenge.

View Article and Find Full Text PDF

Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.

Br J Pharmacol

April 2019

Novartis Pharmaceuticals Corporation, Fort Worth, TX, 76134, USA.

In contrast to the availability of potent and selective antagonists of several prostaglandin receptor types (including DP , DP , EP and TP receptors), there has been a paucity of well-characterized, selective FP receptor antagonists. The earliest ones included dimethyl amide and dimethyl amine derivatives of PGF , but these have failed to gain prominence. The fluorinated PGF analogues, AL-8810 and AL-3138, were subsequently discovered as competitive and non-competitive FP receptor antagonists respectively.

View Article and Find Full Text PDF
Article Synopsis
  • Collagenase is crucial for collagen breakdown in processes like wound healing and cancer spread, but its degradation mechanism is not fully understood.
  • The study investigates how substituting D-Alanine in collagen-like peptides affects their structure and stability against collagenase hydrolysis, using circular dichroic spectroscopy.
  • Findings indicate that D-Alanine enhances the formation of a specific peptide conformation, which may inhibit collagenase activity and could be useful for developing new peptide-based materials that interact with enzymes.
View Article and Find Full Text PDF

Alzheimer's disease (AD) is the most common form of dementia and currently affects 5.4 million Americans. A number of anti-Aβ (beta amyloid) therapeutic agents have been developed for AD, but so far all of them failed in clinic.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!